Greenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01
Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026
Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026
Steadright Files Q1 Interim FS and MD&A / Moroccan Site and Cancellation of Crushing & Grinding Equipment Share Purchase Agreement With Possible Renegotiation
